Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022

Rhea-AI Summary

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) will participate in Maxim Group's 2022 Virtual Growth Conference from March 28-30, 2022. A presentation by Founder and CEO Payton Nyquvest will be available on-demand starting March 28 at 9:00 a.m. ET. Interested participants can register here. Numinus focuses on innovative mental health care and evidence-based psychedelic therapies aimed at addressing conditions like depression and anxiety.

VANCOUVER, BC, March 15, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in Maxim Group's 2022 Virtual Growth Conference to be held virtually on March 28-30, 2022.

A corporate presentation from Payton Nyquvest, Founder and CEO of Numinus, will be available on-demand starting Monday, March 28^th at 9:00 a.m. ET. To attend, please register here.

For more information about the Maxim conference, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate Maxim representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.

About Numinus
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.

Forward-looking statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-maxims-2022-virtual-growth-conference-on-march-28-30-2022-301502601.html

SOURCE Numinus Wellness Inc.

FAQ

When will Numinus participate in the Maxim Group 2022 Virtual Growth Conference?

Numinus will participate in the Maxim Group 2022 Virtual Growth Conference from March 28-30, 2022.

Who will present for Numinus at the conference?

Payton Nyquvest, Founder and CEO of Numinus, will present at the conference.

What time will Numinus's presentation be available?

The presentation will be available on-demand starting March 28 at 9:00 a.m. ET.

How can I register for the Numinus conference presentation?

You can register for the Numinus conference presentation here.

What is the focus of Numinus Wellness?

Numinus Wellness focuses on innovative mental health care and safe, evidence-based psychedelic-assisted therapies for conditions such as anxiety and depression.